Labcorp Holdings Inc. (LH) To Go Ex-Dividend on November 24th

Labcorp Holdings Inc. (NYSE:LH) announced a quarterly dividend on Tuesday, October 20th. Stockholders of record on Tuesday, November 24th will be paid a dividend of $0.72 per share by the medical research company on Friday, December 11th. This represents a $2.88 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, November 24th.

Labcorp has a dividend payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Labcorp to earn $19.69 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 14.6%.

Labcorp Price Performance

Shares of LH traded up $0.52 on Thursday, reaching $324.27. The stock had a trading volume of 100,751 shares, compared to its average volume of 686,234. The firm has a market capitalization of $26.30 billion, a PE ratio of 26.72, a PEG ratio of 1.84 and a beta of 0.87. The company has a quick ratio of 1.53, a current ratio of 1.80 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average of $320.56 and a 200 day moving average of $290.33. Labcorp has a twelve month low of $244.52 and a twelve month high of $341.80.

Labcorp (NYSE:LH) last released its quarterly earnings data on Thursday, July 30th. The medical research company reported $4.99 earnings per share for the quarter, beating the consensus estimate of $4.78 by $0.21. The firm had revenue of $3.73 billion during the quarter, compared to the consensus estimate of $3.71 billion. Labcorp had a return on equity of 16.74% and a net margin of 6.99%. Labcorp’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the business posted $4.35 EPS. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. Sell-side analysts expect that Labcorp will post 18.32 EPS for the current year.

About Labcorp

Labcorp (NYSE: LH), formally Laboratory Corporation of America Holdings, is a global life sciences and healthcare company headquartered in Burlington, North Carolina. The company provides laboratory testing and diagnostic services to physicians, hospitals, health systems, employers, insurers and consumers.

Through its diagnostics operations, Labcorp offers routine and specialty testing, oncology diagnostics, women’s health testing, genetic testing, pathology services and other laboratory services.